Last reviewed · How we verify

etoricoxib 60mg

Muhammad Ilyas · FDA-approved active Small molecule Quality 5/100

etoricoxib 60mg is a Small molecule drug developed by Muhammad Ilyas. It is currently FDA-approved. Also known as: pregabalin 75mg.

At a glance

Generic nameetoricoxib 60mg
Also known aspregabalin 75mg
SponsorMuhammad Ilyas
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about etoricoxib 60mg

What is etoricoxib 60mg?

etoricoxib 60mg is a Small molecule drug developed by Muhammad Ilyas.

Who makes etoricoxib 60mg?

etoricoxib 60mg is developed and marketed by Muhammad Ilyas (see full Muhammad Ilyas pipeline at /company/muhammad-ilyas).

Is etoricoxib 60mg also known as anything else?

etoricoxib 60mg is also known as pregabalin 75mg.

What development phase is etoricoxib 60mg in?

etoricoxib 60mg is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing